Literature DB >> 13080970

Therapeutic evaluation of a new anticoagulant, phenylindandione.

W W COON, I F DUFF, P E HODGSON, E W DENNIS.   

Abstract

Entities:  

Keywords:  PHENINDIONE/therapeutic use

Mesh:

Substances:

Year:  1953        PMID: 13080970      PMCID: PMC1609531          DOI: 10.1097/00000658-195309000-00019

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  2 in total

1.  A new prothrombopenic drug, phenylindanedione.

Authors:  L B JAQUES; E GORDON E LEPP
Journal:  Can Med Assoc J       Date:  1950-05       Impact factor: 8.262

2.  Preliminary report on the clinical use of a new anticoagulant, phenylindandione.

Authors:  A U BLAUSTEIN; J J CROCE; M ALBERIAN; N RICHEY
Journal:  Circulation       Date:  1950-05       Impact factor: 29.690

  2 in total
  6 in total

1.  PHENINDIONE NEPHROPATHY WITH RECOVERY: STUDIES OF MORPHOLOGY AND RENAL FUNCTION.

Authors:  H A LEE; C E HOLDEN
Journal:  Postgrad Med J       Date:  1964-06       Impact factor: 2.401

2.  PHENINDIONE SENSITIVITY.

Authors:  A HOLLMAN; H O WONG
Journal:  Br Med J       Date:  1964-09-19

3.  Anticoagulants and arteriosclerosis.

Authors:  K BALL
Journal:  Postgrad Med J       Date:  1955-03       Impact factor: 2.401

4.  Acute interstitial nephritis due to drug sensitivity.

Authors:  S B BAKER; R T WILLIAMS
Journal:  Br Med J       Date:  1963-06-22

5.  Clinical evaluation of miradon.

Authors:  G KELLAWAY
Journal:  Br Med J       Date:  1958-10-11

6.  Severe sensitivity reaction (hepatitis, dermatitis and pyrexia) attributable to phenylindanedione.

Authors:  E N EAST; R E BEAMISH
Journal:  Can Med Assoc J       Date:  1957-12-01       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.